These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24814493)

  • 1. Reply: application of the gompertz method for evaluating survival gains in patients receiving cardiac resynchronization therapy.
    Finegold JA; Francis DP
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2879-80. PubMed ID: 24814493
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of the gompertz method for evaluating survival gains in patients receiving cardiac resynchronization therapy.
    Messori A; Fadda V; Maratea D; Trippoli S
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2879. PubMed ID: 24814490
    [No Abstract]   [Full Text] [Related]  

  • 3. Why are clinically indicated, but lower-risk, patients less likely to receive implantable cardioverter-defibrillator and cardiac resynchronization therapy?
    Mounsey JP; Schwartz JD
    J Am Coll Cardiol; 2013 Dec; 62(25):2414-2415. PubMed ID: 24013052
    [No Abstract]   [Full Text] [Related]  

  • 4. New developments in cardiac resynchronization therapy.
    Sankaranarayanan R; Visweswariah R; Fox DJ
    Br J Hosp Med (Lond); 2013 Sep; 74(9):503-9. PubMed ID: 24022551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing knowledge and changing views in cardiac resynchronization therapy.
    Buga L; Cleland JG
    Heart Fail Rev; 2012 Nov; 17(6):721-5. PubMed ID: 21932145
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac Resynchronization Therapy in Patients with Heart Failure: What is New?
    Palmiero G; Florio MT; Rubino M; Nesti M; Marchel M; Russo V
    Heart Fail Clin; 2021 Apr; 17(2):289-301. PubMed ID: 33673953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmet Needs and Prioritization in Heart Failure.
    Lund LH; Hauptman PJ
    J Card Fail; 2016 Aug; 22(8):587-8. PubMed ID: 27346716
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart failure in 2011: Heart failure therapy--technology to the fore.
    McMurray JJ
    Nat Rev Cardiol; 2012 Jan; 9(2):73-4. PubMed ID: 22273714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical remodeling after cardiac resynchronization therapy and its relationship with the anatomical remodeling.
    D'Onofrio A; Iuliano A; De Simone A; Pecora D; Rapacciuolo A; Ricciardi G; Marini M; Pepi P; Caico SI; Palmisano P; Giovannini T; Arena G; Maglia G; Ospizio R; Botto GL; Bertaglia E; Stabile G
    Int J Cardiol; 2016 May; 211():86-7. PubMed ID: 26991554
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in the elderly: a realistic option for an increasing population?
    António N; Elvas L; Gonçalves L; Providência LA
    Int J Cardiol; 2012 Feb; 155(1):49-51. PubMed ID: 21334076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy: state of the art 2013.
    Yu CM; Hayes DL
    Eur Heart J; 2013 May; 34(19):1396-403. PubMed ID: 23355652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization: what's next?
    Leclercq C
    Arch Cardiovasc Dis; 2012; 105(6-7):335-7. PubMed ID: 22800717
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac contractility modulation: the next cardiac resynchronization therapy or another renal sympathetic denervation?
    Mentz RJ; Butler J
    J Card Fail; 2015 Jan; 21(1):24-6. PubMed ID: 25463742
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in the optimization of cardiac resynchronization therapy.
    Chandraprakasam S; Mentzer GG
    Curr Heart Fail Rep; 2015 Feb; 12(1):48-60. PubMed ID: 25315038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronisation therapy for heart failure with narrow or normal QRS.
    Yip GW; Fung JW
    Heart; 2011 Jul; 97(13):1029-31. PubMed ID: 21343170
    [No Abstract]   [Full Text] [Related]  

  • 16. The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France.
    Galand V; Linde C; Lellouche N; Mansourati J; Deharo JC; Sagnol P; Da Costa A; Horvilleur J; Defaye P; Boveda S; Steinbach M; Bru P; Rumeau P; Beard T; Younsi S; Dickstein K; Normand C; Leclercq C
    Arch Cardiovasc Dis; 2019 Nov; 112(11):713-722. PubMed ID: 31706879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy: results, challenges and perspectives for the future.
    Ståhlberg M; Braunschweig F; Gadler F; Mortensen L; Lund LH; Linde C
    Scand Cardiovasc J; 2016; 50(5-6):282-292. PubMed ID: 27577107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT).
    Kuschyk J; Nägele H; Heinz-Kuck K; Butter C; Lawo T; Wietholt D; Roeger S; Gutterman D; Burkhoff D; Rousso B; Borggrefe M
    Int J Cardiol; 2019 Feb; 277():173-177. PubMed ID: 30409733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy: a comprehensive review.
    Moskovitch J; Voskoboinik A
    Minerva Med; 2019 Apr; 110(2):121-138. PubMed ID: 30334442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.
    Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V
    J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.